Caspian Journal of Reproductive Medicine
نشریه طب تولید مثل خزر
Caspian J Reprod Med
Medical Sciences
http://caspjrm.ir
1
admin
2423-5660
2423-5660
8
10.22088/caspjrm
14
8888
13
en
jalali
1404
3
1
gregorian
2025
6
1
11
1
online
1
fulltext
en
Histologic comparison of the fallopian pathologic effects of erythropoietin and U-74389G
Obstetrics and Gynecology
Obstetrics and Gynecology
پژوهشي
Original Research
<div class="WordSection1"><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:12.0pt"><span style="text-autospace:none"><span style="font-family:Calibri,"sans-serif""><b><span style="font-size:10.0pt"><span style="font-family:"Times New Roman","serif"">Background:</span></span></b><span style="font-size:10.0pt"><span style="font-family:"Times New Roman","serif""> This study compared the effects of erythropoietin (Epo) and the antioxidant lazaroid U-74389G (L) on fallopian pathology in a rat model of fallopian ischemia-reperfusion (FIR). The comparison was based on two preliminary studies evaluating the effects of each drug in an FIR animal model.</span></span></span></span></span></span><br />
<span style="font-size:11pt"><span style="line-height:12.0pt"><span style="text-autospace:none"><span style="font-family:Calibri,"sans-serif""><b><span style="font-size:10.0pt"><span style="font-family:"Times New Roman","serif"">Methods:</span></span></b><span style="font-size:10.0pt"><span style="font-family:"Times New Roman","serif""> Fallopian pathology was assessed at two endpoints: 60 minutes (groups A, C, E) and 120 minutes (groups B, D, F) of reperfusion. Groups A and B received no drugs, groups C and D received Epo, and groups E and F received U-74389G.</span></span></span></span></span></span><br />
<span style="font-size:11pt"><span style="line-height:12.0pt"><span style="text-autospace:none"><span style="font-family:Calibri,"sans-serif""><b><span style="font-size:10.0pt"><span style="font-family:"Times New Roman","serif"">Results:</span></span></b><span style="font-size:10.0pt"><span style="font-family:"Times New Roman","serif""> The Epo study showed a non-significant reduction in total fallopian pathology within the “lesion-free” grade by -0.01 (95% CI: -0.09 to 0.06). The U-74389G study showed a non-significant increase in pathology by 0.01 (95% CI: -0.05 to 0.06). Co-evaluation indicated that Epo slightly ameliorated fallopian pathology, while U-74389G slightly worsened it, though the difference was non-significant.</span></span></span></span></span></span><br />
<span style="font-size:11pt"><span style="line-height:12.0pt"><span style="text-autospace:none"><span style="font-family:Calibri,"sans-serif""><b><span style="font-size:10.0pt"><span style="font-family:"Times New Roman","serif"">Conclusion:</span></span></b><span style="font-size:10.0pt"><span style="font-family:"Times New Roman","serif""> Epo demonstrates a slight, non-significant superiority over U-74389G in restoring fallopian pathology, potentially applicable in clinical settings.</span></span></span></span></span></span><br />
<span style="font-size:11pt"><span style="line-height:12.0pt"><span style="text-autospace:none"><span style="font-family:Calibri,"sans-serif""><b><span style="font-size:10.0pt"><span style="font-family:"Times New Roman","serif""><span style="color:#006699">Keywords: </span></span></span></b><span style="font-size:10.0pt"><span style="font-family:"Times New Roman","serif"">Erythropoietin, Fallopian tubes, Ischemia, Reperfusion, U-74389G</span></span></span></span></span></span></span></div>
Erythropoietin, Fallopian tubes, Ischemia, Reperfusion, U-74389G
12
16
http://caspjrm.ir/browse.php?a_code=A-12-159-2&slc_lang=en&sid=1
Constantinos
Tsompos
constantinos1tsompos@gmail.com
10031947532846002518
10031947532846002518
Yes
Department of Gynecology, General Hospital of Athens “G. Gennimatas”, Attiki, HELLAS
Constantinos
Panoulis
10031947532846002519
10031947532846002519
No
Aggeliki
Triantafyllou
10031947532846002520
10031947532846002520
No
Constantinos
Zografos
10031947532846002521
10031947532846002521
No
George C.
Zografos
10031947532846002522
10031947532846002522
No
Apostolos
Papalois
10031947532846002523
10031947532846002523
No